To further investigate the detailed information between TRIM47 and ADAR, we applied treatment with a proteasome inhibitor MG132 to differentiated thyroid carcinoma FTD-133 cells combining with the short hairpin RNAs with TRIM47-#1 and Sh-TRIM47-#2 specific against TRIM47, and the TRIM47 overexpression. Here, TRIM47 is linked to thyroid gland carcinoma.